Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Lane

Showing results (41-50 of 235) with videos related to

Pageof 24
Sort By:
Biomolecules|August 6, 2021
Can Glycosylation Mask the Detection of MHC Expressing p53 Peptides by T Cell Receptors?Thanh Binh Nguyen, David P Lane, Chandra S Verma
Plos One|September 7, 2012
Stapled BH3 peptides against MCL-1: mechanism and design using atomistic simulationsThomas L Joseph, David P Lane, Chandra S Verma
The Journal of Pathology|December 3, 2010
The role of mutant p53 in human cancerAmanda M Goh, Cynthia R Coffill, David P Lane
FEBS Letters|February 15, 2003
Differences in the ubiquitination of p53 by Mdm2 and the HPV protein E6Suzanne Camus, Maureen Higgins, David P Lane, et al.
EMBO Reports|February 5, 2008
Molecular simulations of protein dynamics: new windows on mechanisms in biologyGuy G Dodson, David P Lane, Chandra S Verma
Cell Cycle (Georgetown, Tex.)|May 24, 2012
Why is F19Ap53 unable to bind MDM2? Simulations suggest crack propagation modulates bindingShubhra Ghosh Dastidar, David P Lane, Chandra S Verma
Oncogene|September 21, 2002
Cell type-specific responses of human cells to inhibition of replication licensingS Shreeram, Alison Sparks, David P Lane, et al.
Molecular and Cellular Biology|August 9, 2002
Hypophosphorylation of Mdm2 augments p53 stabilityChristine Blattner, Trevor Hay, David W Meek, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 15, 2019
Functionalized Resins for the Synthesis of Peptide AlcoholsFernando J Ferrer-Gago, Li Quan Koh, David P Lane
Nature Reviews. Clinical Oncology|October 27, 2010
Translating p53 into the clinicChit Fang Cheok, Chandra S Verma, José Baselga, et al.
Pageof 24

Showing results (41-50 of 235) with videos related to

Sort By:
Pageof 24
Biomolecules|August 6, 2021
Can Glycosylation Mask the Detection of MHC Expressing p53 Peptides by T Cell Receptors?Thanh Binh Nguyen, David P Lane, Chandra S Verma
Plos One|September 7, 2012
Stapled BH3 peptides against MCL-1: mechanism and design using atomistic simulationsThomas L Joseph, David P Lane, Chandra S Verma
The Journal of Pathology|December 3, 2010
The role of mutant p53 in human cancerAmanda M Goh, Cynthia R Coffill, David P Lane
FEBS Letters|February 15, 2003
Differences in the ubiquitination of p53 by Mdm2 and the HPV protein E6Suzanne Camus, Maureen Higgins, David P Lane, et al.
EMBO Reports|February 5, 2008
Molecular simulations of protein dynamics: new windows on mechanisms in biologyGuy G Dodson, David P Lane, Chandra S Verma
Cell Cycle (Georgetown, Tex.)|May 24, 2012
Why is F19Ap53 unable to bind MDM2? Simulations suggest crack propagation modulates bindingShubhra Ghosh Dastidar, David P Lane, Chandra S Verma
Oncogene|September 21, 2002
Cell type-specific responses of human cells to inhibition of replication licensingS Shreeram, Alison Sparks, David P Lane, et al.
Molecular and Cellular Biology|August 9, 2002
Hypophosphorylation of Mdm2 augments p53 stabilityChristine Blattner, Trevor Hay, David W Meek, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 15, 2019
Functionalized Resins for the Synthesis of Peptide AlcoholsFernando J Ferrer-Gago, Li Quan Koh, David P Lane
Nature Reviews. Clinical Oncology|October 27, 2010
Translating p53 into the clinicChit Fang Cheok, Chandra S Verma, José Baselga, et al.
Pageof 24